{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:26:28Z","timestamp":1790799988233,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.bcp.2006.12.015","type":"journal-article","created":{"date-parts":[[2006,12,16]],"date-time":"2006-12-16T12:14:20Z","timestamp":1166271260000},"page":"1376-1383","source":"Crossref","is-referenced-by-count":48,"title":["Selective action of the iminosugar isofagomine, a pharmacological chaperone for mutant forms of acid-\u03b2-glucosidase"],"prefix":"10.1016","volume":"73","author":[{"given":"Richard","family":"Steet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-Sik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey W.","family":"Pine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Kornfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2006.12.015_bib1","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1172\/JCI105417","article-title":"Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease","volume":"45","author":"Brady","year":"1966","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2006.12.015_bib2","first-page":"377","article-title":"Gaucher disease. Enzymology, genetics, and treatment","volume":"21","author":"Grabowski","year":"1993","journal-title":"Adv Hum Genet"},{"key":"10.1016\/j.bcp.2006.12.015_bib3","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00018-005-5437-0","article-title":"Therapeutic strategies to ameliorate lysosomal storage disorders\u2014a focus on Gaucher disease","volume":"63","author":"Sawkar","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bcp.2006.12.015_bib4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ana.410420412","article-title":"Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease","volume":"42","author":"Schiffmann","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bcp.2006.12.015_bib5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/B:BOLI.0000045756.54006.17","article-title":"Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin OGT 918) in type I Gaucher disease","volume":"27","author":"Elstein","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bcp.2006.12.015_bib6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10545-006-0272-5","article-title":"Substrate reduction therapy of glycosphingolipid storage disorders","volume":"29","author":"Aerts","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bcp.2006.12.015_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ajh.20504","article-title":"Guidance on the use of miglustat for treating patients with type 1 Gaucher disease","volume":"80","author":"Weinreb","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bcp.2006.12.015_bib8","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.clinthera.2005.08.004","article-title":"An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment","volume":"27","author":"Pastores","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.bcp.2006.12.015_bib9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0006-2952(99)00384-6","article-title":"N-Butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo","volume":"59","author":"Andersson","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2006.12.015_bib10","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0605928103","article-title":"The iminosugar isofagomine increases the activity of N370S mutant acid \u03b2-glucosidase in Gaucher fibroblasts by several mechanisms","author":"Steet","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2006.12.015_bib11","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1111\/j.1742-4658.2006.05410.x","article-title":"Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients","volume":"273","author":"Chang","year":"2006","journal-title":"FEBS J"},{"key":"10.1016\/j.bcp.2006.12.015_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bcmd.2005.05.007","article-title":"Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations","volume":"35","author":"Alfonso","year":"2005","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.bcp.2006.12.015_bib13","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2005.09.007","article-title":"Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles","volume":"12","author":"Sawkar","year":"2005","journal-title":"Chem Biol"},{"key":"10.1016\/j.bcp.2006.12.015_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbadis.2004.03.007","article-title":"N-Octyl-beta-valienamine up-regulates activity of F213I mutant beta-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease","volume":"1689","author":"Lin","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2006.12.015_bib15","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S beta-glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2006.12.015_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0304-4165(92)90105-4","article-title":"A rapid and simple assay method for UDP-glucose:ceramide glucosyltransferase","volume":"1116","author":"Matsuo","year":"1992","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2006.12.015_bib17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm1041","article-title":"Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder","volume":"10","author":"Wu","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2006.12.015_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1010335505357","article-title":"Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy","volume":"24","author":"Platt","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bcp.2006.12.015_bib19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1146\/annurev.bi.54.070185.003215","article-title":"Assembly of asparagine-linked oligosaccharides","volume":"54","author":"Kornfeld","year":"1985","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.bcp.2006.12.015_bib20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0300-9084(03)00049-X","article-title":"The role of glucosidase II and endomannosidase in glucose trimming of asparagine-linked oligosaccharides","volume":"85","author":"Roth","year":"2003","journal-title":"Biochimie"},{"key":"10.1016\/j.bcp.2006.12.015_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1146\/annurev.bi.56.070187.002433","article-title":"Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains","volume":"56","author":"Elbein","year":"1987","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.bcp.2006.12.015_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0009-8981(77)90402-8","article-title":"Urinary alpha-glucosidase analysis for the detection of the adult form of Pompe's disease","volume":"77","author":"Soyama","year":"1977","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.bcp.2006.12.015_bib23","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1016\/S0021-9258(19)67833-6","article-title":"alpha-Glucosidase II-deficient cells use endo alpha-mannosidase as a bypass route for N-linked oligosaccharide processing","volume":"266","author":"Fujimoto","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2006.12.015_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005176-199507000-00001","article-title":"Congenital sucrase\u2013isomaltase deficiency","volume":"21","author":"Treem","year":"1995","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.bcp.2006.12.015_bib25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1172\/JCI113646","article-title":"Sucrase\u2013isomaltase deficiency in humans. Different mutations disrupt intracellular transport, processing, and function of an intestinal brush border enzyme","volume":"82","author":"Naim","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2006.12.015_bib26","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1021\/bi9522514","article-title":"Evaluation of isofagomine and its derivatives as potent glycosidase inhibitors","volume":"35","author":"Dong","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2006.12.015_bib27","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1073\/pnas.91.3.913","article-title":"Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control","volume":"91","author":"Hammond","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2006.12.015_bib28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0968-0896(00)00291-1","article-title":"Iminosugars: potential inhibitors of liver glycogen phosphorylase","volume":"9","author":"Jakobsen","year":"2001","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bcp.2006.12.015_bib29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0197-0186(99)00146-1","article-title":"The effects of isofagomine, a potent glycogen phosphorylase inhibitor, on glycogen metabolism in cultured mouse cortical astrocytes","volume":"36","author":"Waagepetersen","year":"2000","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bcp.2006.12.015_bib30","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s11064-005-8801-4","article-title":"Compartmentation of lactate originating from glycogen and glucose in cultured astrocytes","volume":"30","author":"Sickmann","year":"2005","journal-title":"Neurochem Res"},{"key":"10.1016\/j.bcp.2006.12.015_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jnr.20335","article-title":"Astrocyte glycogen metabolism is required for neural activity during aglycemia or intense stimulation in mouse white matter","volume":"79","author":"Brown","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bcp.2006.12.015_bib32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bcp.2003.09.036","article-title":"Inhibition of glycogen breakdown by imino sugars in vitro and in vivo","volume":"67","author":"Andersson","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2006.12.015_bib33","doi-asserted-by":"crossref","first-page":"27108","DOI":"10.1016\/S0021-9258(18)47132-3","article-title":"N- butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing","volume":"269","author":"Platt","year":"1994","journal-title":"J Biol Chem"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295206008239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295206008239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T09:46:19Z","timestamp":1628243179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295206008239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0006295206008239"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2006.12.015","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}